Company Valuation: Burning Rock Biotech Limited

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 15,655 6,329 1,632 695.3 505.4 1,517
Change - -59.57% -74.21% -57.4% -27.31% 200.22%
Enterprise Value (EV) 1 13,439 4,919 775.6 79.16 31.77 1,080
Change - -63.4% -84.23% -89.79% -59.86% 3,298.37%
P/E -21.9x -7.92x -1.66x -1.03x -1.46x -27.1x
PBR 6.53x 3.45x 1.38x 0.88x 0.91x 2.77x
PEG - -0.7x -0.1x 0x 0x 0.3x
Capitalization / Revenue 36.4x 12.5x 2.9x 1.29x 0.98x 2.81x
EV / Revenue 31.3x 9.69x 1.38x 0.15x 0.06x 2x
EV / EBITDA -35.4x -6.54x -0.9x -0.15x -0.12x -32.5x
EV / EBIT -32.6x -6.17x -0.79x -0.12x -0.1x -19.7x
EV / FCF -621x -16.1x -3.52x -1.38x -4.12x -47.4x
FCF Yield -0.16% -6.21% -28.4% -72.6% -24.3% -2.11%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -68.76 -76.45 -93.47 -63.84 -33.67 -5.206
Distribution rate - - - - - -
Net sales 1 429.9 507.9 563.2 537.4 515.8 539.6
EBITDA 1 -379.9 -752.5 -859.7 -537.9 -271 -33.22
EBIT 1 -412.4 -797.1 -980.4 -669.3 -322.4 -54.84
Net income 1 -407.2 -796.7 -971.2 -653.7 -346.6 -55.35
Net Debt 1 -2,216 -1,410 -856.8 -616.2 -473.7 -437.7
Reference price 2 1,508.11 605.40 155.19 65.95 49.27 140.94
Nbr of stocks (in thousands) 10,380 10,455 10,519 10,544 10,259 10,767
Announcement Date 3/23/21 A 4/29/22 A 4/20/23 A 4/29/24 A 4/29/25 A 4/28/26 A
1CNY in Million2CNY
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 200M
-297.15x20.17x-349.04x-.--% 59.75B
22.16x2.05x11.73x0.94% 25.04B
15.53x1.21x6.83x5.71% 6.46B
1009.29x - - - 5.56B
52.63x9.73x33.49x0.96% 3.4B
-63.26x - - -.--% 2.41B
15.63x1.66x6.49x5.21% 2.29B
-22.59x - - - 2.26B
31.93x1.67x12.49x1.41% 1.92B
Average 84.91x 6.08x -46.34x 2.03% 10.93B
Weighted average by Cap. -104.65x 13.19x -206.00x 0.77%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. BNR Stock
  4. Valuation Burning Rock Biotech Limited